Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

RNA Splicing

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

RNA Splicing

RNA Splicing

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Journal of the American Chemical Society·2026

Same author

<i>Ppm1d</i> Clonal Hematopoiesis Does Not Promote Atherosclerosis in Murine Models.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

Clonal hematopoiesis in lung adenocarcinoma pathogenesis.

JCI insight·2026

Same author

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Blood·2026

Same author

Charged molecular glue discovery enabled by targeted degron display.

Nature chemical biology·2026

Same author

Endogenous aldehydes: A driver of clonal hematopoiesis from within?

Cell stem cell·2026

Search research articles

Related Experiment Video

Updated: Apr 12, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Charting the "Splice" Routes to MDS.

Esther A Obeng¹, Benjamin L Ebert²

¹Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.

|May 13, 2015

Summary

Mutations affecting mRNA splicing are common in myelodysplastic syndromes (MDS). Recent studies reveal how these splicing factor defects impact blood cell development and MDS progression.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Related Experiment Videos

Last Updated: Apr 12, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Area of Science:

Molecular Biology
Hematology
Oncology

Background:

Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
Approximately 50% of MDS cases involve mutations in the 3' mRNA splicing machinery.

Purpose of the Study:

To investigate the impact of mutated or dysregulated splicing factors on hematopoiesis.
To elucidate the role of splicing factor defects in mRNA splicing alterations.
To understand the contribution of these mutations to MDS pathogenesis.

Main Methods:

Analysis of mutations in splicing factors.
Assessment of hematopoietic stem cell function.
Evaluation of mRNA splicing patterns.
Studies on MDS models.

Main Results:

Mutated splicing factors lead to aberrant mRNA splicing.
Splicing factor dysregulation impairs normal hematopoiesis.
These molecular defects contribute to the development and progression of MDS.

Conclusions:

Splicing factor mutations are a key driver in MDS pathogenesis.
Targeting splicing factor defects may offer therapeutic strategies for MDS.
Understanding splicing alterations is crucial for MDS treatment.